A Study of the Safety of Treatment with Iluvien® by Assessing Intraocular Pressure Signals in Patients with Diabetic Macular Edema

Overview

About this study

The purpose of this study is to evaluate the safety of using iluvien to treat patients with diabetic macular edema, by assessing intraocular pressure.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria 

  • Eligible for treatment with Iluvien based on the prescribing information

 

Exclusion Criteria 

  •  Unable to understand and sign the informed consent form

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Andrew Barkmeier, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20178008

Mayo Clinic Footer